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Background: The ability of chemicals to disrupt neonatal development can be studied using embryonic stem cells
(ESC). One such chemical is nicotine. Prenatal nicotine exposure is known to affect postnatal lung function,
although the mechanisms by which it has this effect are not clear. Since fibroblasts are a critical component of the
developing lung, providing structure and secreting paracrine factors that are essential to epithelialization, this study
focuses on the differentiation of ESC into fibroblasts using a directed differentiation protocol.
Methods: Fibroblasts obtained from non-human primate ESC (nhpESC) differentiation were analyzed by immuno-
histochemistry, immunostaining, Affymetrix gene expression array, qPCR, and immunoblotting.
Results: Results of these analyses demonstrated that although nhpESCs differentiate into fibroblasts in the presence
of nicotine and appear normal by some measures, including H&E and SMA staining, they have an altered gene
expression profile. Network analysis of expression changes demonstrated an over-representation of cell-cycle related
genes with downregulation of N-myc as a central regulator in the pathway. Further investigation demonstrated that
cells differentiated in the presence of nicotine had decreased N-myc mRNA and protein expression and longer
doubling times, a biological effect consistent with downregulation of N-myc.
Conclusions: This study is the first to use primate ESC to demonstrate that nicotine can affect cellular
differentiation from pluripotency into fibroblasts, and in particular, mediate N-myc expression in differentiating ESCs.
Given the crucial role of fibroblasts throughout the body, this has important implications for the effect of cigarette
smoke exposure on human development not only in the lung, but in organogenesis in general.
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Maternal exposure to nicotine is known to lead to alter-
ations in postnatal lung function. Nicotine freely passes
through the placenta and can accumulate in amniotic fluid
[1,2]. Studies using non-human primates have shown that
nicotine exposure during development leads to the overex-
pression of some nicotinic acetylcholine receptors (nAChR)
as well as some specific genes and proteins such as colla-
gens in the developed lung [3-5]. In addition, pulmonary* Correspondence: Dlc4@pitt.edu
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distribution, and reproduction in any mediumfunction assessments of non-human primates exposed to
prenatal nicotine demonstrated decreased forced expiratory
flows that mimic the decreased forced expiratory flows
measured in human infants who were exposed to maternal
cigarette smoke [3], implying that among the many chem-
ical present in cigarette smoke with the potential to affect
development, nicotine may have a significant role in the de-
creased pulmonary function in infants exposed to maternal
smoking. However, the mechanisms by which nicotine af-
fects lung development are not well understood.
The ability to use embryonic stem cells (ESCs) as tools
for the study of developmental biology and, in particular, as
sensors to determine the adverse effects of chemical expo-
sures during development was recognized even before pri-
mate embryonic stem cells were first derived [6]. ESCs are
now in use for the study of developmental cardiotoxicityentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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of embryonic development and the effect of environmental
exposures are difficult in animals and impossible in
humans. Directed-differentiation protocols shed insight
into these early stages by allowing investigation of differen-
tiation of ESCs as they move towards more mature cell
types ([11] for review). As protocols for differentiating ESCs
become more established, we can move our focus to using
cells in these models to examine the effects of chemical ex-
posures during the differentiation process. In this study, we
focus on the differentiation of ESC into fibroblasts. Fibro-
blasts are a critical component of the lung and direct epi-
thelialization of the lung through paracrine and other
methods, and prenatal nicotine exposure has been demon-
strated to increase collagen and airway wall thickness, af-
fecting airway resistance [4]. Thus, changes in fibroblast
phenotype during development may affect lung function
after birth.
Non-human primate embryonic stem cells (nhpESC)
are available [12-21] and provide an opportunity to cor-
relate in vivo physiologic data from previous studies with
analysis of intracellular signaling. We have published a
series of related nhpESC lines derived from Rhesus
macaca [12,22]. These lines are more than 95% identical
in their gene expression patterns, making them ideal for
array analysis of gene expression [22,23]. In this study
we use these lines as sensors to assess alterations in dif-
ferentiation that result from nicotine exposure.
NAChR have been shown to be expressed on many
cell types, and the endogenous ligand, acetylcholine, is
expressed ubiquitously (reviews by [24-30]). Nicotine ex-
posure in vitro leads to alterations in the differentiation
of keratinocytes [31,32] and causes release of chromo-
granin A from pheochromocytoma cells [33]. Thus,
nicotine has been previously demonstrated to affect cel-
lular differentiation processes in some somatic tissues,
although neither nhpESC nor hESC have been examined
for the expression of nAChR or for the effect of nicotine
on the differentiation process. In this study, the expres-
sion of nAChR was confirmed in nhpESC, and directed
differentiation of nhpESC into fibroblasts was carried
out in the presence or absence of nicotine. Microarray
analysis of the resulting differentiated cells includes a
number of previously unreported targets of nicotine
regulation. These changes are specific to the differenti-
ation process, and alterations of these genes by nicotine
during development could contribute to the decreased
lung function seen in infants exposed to maternal
nicotine.
Methods
All experiments involving animals were approved by the
Institutional Animal Care and Use Committees
(IACUCs) from the Magee-Womens Research Instituteand the University of Pittsburgh and experiments involv-
ing embryonic stem cells were approved by the Univer-
sity of Pittsburgh Human Stem Cell Research Oversight
(hSCRO) committee.
Cell lines
NhpESC cell lines were a generous gift from Gerald
Schatten (U. Pittsburgh). NhpESC lines were previously
described ([12], personal communication). Primary adult
non-human primate lung fibroblasts were obtained dur-
ing necropsy by taking tissue biopsies. Tissues were
minced and grown in DMEM with 15% serum, 1% peni-
cillin/streptomycin, and 2 mM L-glutamine.
NhpESC culture
NhpESCs were cultured in 80% KO-DMEM (Invitrogen,
Carlsbad, CA), 20% Knockout Serum Replacement (Invi-
trogen), 1 mM L-glutamine (Invitrogen), 0.1 mM non-
essential amino acids (Invitrogen), and 4 ng/ml basic hu-
man recombinant FGF (Invitrogen). NhpESCs were
grown on inactivated mouse embryonic feeder cells
(MEF’s) and manually passaged weekly. Media was
replaced every 24 hours [12].
Pluripotency marker expression
NhpESCs were fully characterized to demonstrate pluri-
potency using a teratoma assay [22]. To ensure nhpESCs
maintained a pluripotent phenotype throughout the
experiments, cells were stained for the positive pluripo-
tency markers: Oct-4, SSEA-4, Tra 1–80 and Tra 1–61,
as well as the negative nhpESC marker SSEA-1.
Immunocytochemistry was performed as follows:
Culture dishes containing undifferentiated colonies were
fixed by addition of either 100% methanol at −20°C for
15 min, or 2% paraformaldehyde in PBS for 40 minutes
followed by a 15 min wash in PBS + 1% Triton X-100
(PBS-Tx, Sigma, St. Louis MO). After fixation, non-
specific binding of the primary and secondary antibodies
was blocked by 30 minutes incubation in PBS with 0.5%
goat serum. Primary antibodies were diluted in PBS-Tx
and incubated on the coverslips for 40 min at 37°C in a
humidified chamber, with the exception of Oct-4 which
was incubated overnight at 4°C. Primary antibodies were
detected with fluorescently labeled appropriate second-
ary antibodies. DNA was detected with 5 μM TOTO-3
(Molecular Probes, Eugene OR). Coverslips were
inverted onto slides and mounted in Vectashield anti-
fade medium (Vector Labs, Burlingame, NH) to prevent
photobleaching [22].
In Vitro differentiation
Colonies were manually passaged and dissociated into small
clusters. They were cultured in non-adherent dishes
to form embryoid bodies in differentiation medium (80%
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essential amino acids). After 4 days in suspension, aggre-
gates were transferred onto gelatin coated culture dishes
and cultured for an additional 9 days in differentiation
medium. Outgrowth cultures were manually passaged by
scraping cells with a differentiated phenotype from the
periphery of the colonies, and these differentiated cells
were placed in a new culture plate in differentiation
medium. After the first passage, cells were grown in
standard fibroblast media (90% KO-DMEM, 10% FBS,
1% non-essential amino acids, 2 mM L-glutamine) and
passaged at 80% confluency using trypsin. Cells were
banked at each passage and were cultured until they
stopped growing or through passage 10. Experimental
groups were treated with 100 nM nicotine starting on
day 1 of the differentiation protocol.PCR for nAChR
RT-PCR for nAChR was done using primer sequences
that have been previously published [34]. All primers
span introns and do not amplify DNA. GAPDH or actin
was always used as a positive control for RNA integrity.
Oligo dT12-18 (Invitrogen) was annealed to 1 μg total
RNA and reverse transcribed with Superscript II (Invi-
trogen). The reaction contained 1 μg RNA, 500 ng Oligo
dT12-18, 50 mM Tris–HCl, pH 8.3, 75 mM KCl, 3 mM
MgCl2, 10 mM DTT, 1 mM each dNTP, 200 U super-
script. Briefly, total RNA was incubated with oligo
dT12-18 at 70.0°C for 10 min. The cDNA produced was
then used as a template for PCR using specific primers.
PCR amplification was performed in a 20 μl reaction
containing 2 μl of the RT reaction, Taq DNA polymerase
(Perkin Elmer), 1X PCR buffer, 1.5 mM MgCl2, 1 mM
each dNTP and 1 μM primer. PCR was carried out in a
Perkin-Elmer 9700 Thermocycler with 2 min, 95.0°C de-
naturation, followed by 30 cycles of 94.0°C for 30 s,
55.0-62.0°C (see [34]) for 30 s and 72.0°C for 30 s. Final
extension was at 72.0°C for 5 min. 10 μl of each reaction
was run on a 1% TBE gel for analysis. β2 and δ subunits
were detected using nested PCR. Primary PCR reactions
were carried out as described above. 2 μl of the primary
reaction was used as the template for the secondary PCR
reaction/second round PCR. Thirty rounds of PCR were
carried out.Teratoma analysis
Differentiated fibroblasts were tested for their ability to
form teratomas in the testes of mice. The analysis was
done at the MWRIF Transgenic Core Facility according
to their standard methods [12,22,35-38]. Pathology on
the testes was performed by the MWRIF Histology
Research Core Facility.Gene expression analysis
Gene expression analysis was performed by the DNA Ana-
lysis group at the University of Pittsburgh Genomics and
Proteomic Core Laboratory using cell pellets provided by
D. Carlisle’s laboratory as described herein. RNA was iso-
lated from in vitro differentiated fibroblasts from three dif-
ferent nhpESC lines, each differentiated in the presence
and absence of nicotine: nhpESC2706, nhpESC3106 and
nhpESC4706. Three technical replicates were done with
each cell line and condition, and cultures with and without
nicotine were matched for passage number after differenti-
ation. RNA Isolation: RNA was purified using a modified
Trizol extraction method (Invitrogen, Carlsbad, CA).
Briefly, suspended cells were extracted in 1 mL of Trizol
with the addition of 200 μg of GlycoBlue (Ambion Inc,
Austin, TX) added to each sample as a nucleotide carrier.
After aqueous phase separation, the samples were incu-
bated overnight at 20°C in 500 μl of isopropanol (100%) to
precipitate the RNA. The RNA was then pelleted by centri-
fugation (14,000 g × 15 min), washed in 1 mL of 75% etha-
nol, and resuspended in 20 μl nuclease-free water at 45°C
for 5 minutes. The RNA concentration and quality was
evaluated with criteria for inclusion in subsequent in vitro
transcription (IVT) assays comprising spectrophotometric
absorption ratio of 260/280 >1.8 (NanoDrop, Wilmington,
DE) and a RIN value of >8.0 via electrophoretic analysis
(Agilent Bioanalyzer 2100, Agilent Technologies, Santa
Clara, CA). Affymetrix Eukaryotic Target Preparation and
Hybridization: In vitro transcription was performed using
the Ambion Message Amp II-Biotin Enhanced Assay
protocol starting with 100 ng of purified total RNA. Con-
firmation of cRNA diversity was obtained using the Bioana-
lyzer 2100 to generate an electrophoretogram for each IVT
reaction regarding sample yield, integrity, and size diversity
against a Universal Human Reference RNA (Stratagene, La
Jolla, CA). Fifteen micrograms of purified, biotin labeled
cRNA was fragmented and hybridized on Rhesus Macaque
Whole Genome Arrays (Affymetrix Corp., Santa Clara,
CA) for 18 hours. Washing, staining and scanning of arrays
were performed on the Fluidics Station 450 and Scanner
3000 immediately after completion of hybridization. Micro-
array data was processed using GeneChip Operating Soft-
ware (GCOS, Affymetrix) with signal intensity calculated
by Microarray Suite version 5.0 (MAS 5.0).Statistical analysis
Differential gene expression analysis was performed in con-
sultation with the University of Pittsburgh Genomics Ana-
lysis Services using BRB Array Tools from NCI (http://
linus.nci.nih.gov/BRB-ArrayTools.html), and genes were se-
lected at p < 0.001 (Additional file 1: Table S1). Statistical
analysis of qPCR and immunoblotting was done by t-test,
and analysis of slope for doubling time was done using a
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counts.
Quantitative PCR
Cells were pelleted by centrifugation at 200 × g for
5 min. RNA was isolated using Trizol (Invitrogen).
Briefly, 1 ml of Trizol was added per cell culture dish
and vortexed to lyse cells to homogeneity. 200 μl of
chloroform (Sigma) was added followed by mixing and
centrifugation for five min at 25,000 × g. The RNA con-
taining supernatant was removed and the RNA pelleted
using 600 μl of 100% isopropanol added to the super-
natant and incubated at −20°C for at least 4 hrs. The
sample was centrifuged twice at 13000 × g for 30 min at
4°C, with an ethanol wash in between, followed by air-
drying. The RNA pellet was reconstituted in nuclease
free water and treated with 1 μl DNase I for 30 min at
37°C. cDNA was prepared using the Improm-II Reverse
Transcription System (Promega, Madison WI), accord-
ing to manufacturer’s directions. Validated primer sets
were purchased from Applied Biosystems and were used
on an ABI 7900HT real-time PCR machine. Real-time
data was analyzed and fold change was calculated using
the comparative CT method with either beta-actin or
GADPH as the internal control [39].
Protein isolation and immunoblotting
Proliferating cells at passage 8, 9, or 13 were scraped
from flasks in ice cold PBS/Phosphatase Inhibitors. Cell
pellets were lysed in RIPA Buffer supplemented with a
Protease Inhibitor Cocktail (Roche). The lysate was cen-
trifuged for 20 minutes at 14,000 × g and 4°C in a pre-
cooled microcentrifuge. Protein concentrations of the
clarified lysates were quantitated using the BCA Assay
Kit (Thermo Scientific) and a BSA standard curve fol-
lowing the manufacturer’s instructions. Protein samples
were stored at −80°C. Samples for Western blot analysis
were diluted in 4 × Laemmli buffer (BioRad) supple-
mented with 10% β-mercaptoethanol to a concentration
of 10 μg of protein in 20 μL. Samples were heated at
55°C for 5 minutes and were separated on 10% poly-
acrylamide gels by SDS-PAGE and transferred to
Immobilon-FL PVDF membranes (Millipore) by BioRad
wet transfer. The membranes were blocked with LiCor
Odyssey blocking buffer for 1 hour at room temperature
and were then probed with a primary N-myc antibody
(NCM II 100, Millipore) diluted 1:100 in LiCor Odyssey
blocking buffer with 0.05% Tween. Membranes were
washed three times for 15 minutes each in PBS supple-
mented with 0.05% Tween (TBST) and were subse-
quently probed with goat anti-mouse IR-Dye 800cw
labeled secondary antibody diluted 1:30000 in LiCor
Odyssey blocking buffer. Washes were repeated after la-
beling with secondary antibody three times in PBST andthen once in PBS. Membranes were imaged using LiCor
scanner. Membranes were stripped using LiCor NewBlot
stripping buffer for 15 minutes at room temperature.
Membranes were reprobed with mouse anti-β-actin di-
luted 1:10000 in LiCor Odyssey blocking buffer with
0.05% Tween followed by washes and probing with the
LiCor secondary antibody, then washed and imaged as
described above.
Analysis of culture doubling time
For growth analysis, cells were plated in triplicate in 6-
well plates (Corning Life Sciences, Corning, NY) at a
concentration of 2 × 105 cells/well. After 2, 3, 4, 5, 6,
and 7 days, cells were trypsinized and counted using the
Countess Automated Cell Counter (Invitrogen). Cell
counts were analyzed by logistic regression and doubling
times were calculated using www.doubling-time.com/
compute.php.
Results
Nicotine receptors are expressed on stem cells before
and after differentiation
Lung fibroblasts are known to express nAChR as are
mouse embryonic lung cells [34,40]. The most com-
monly expressed receptors in lung fibroblasts are those
that make up the muscle type nAChR and the alpha7
neuronal nAChR [34,40]. Primate embryonic stem cells,
including human and non-human primate, have not pre-
viously been examined for expression of nAChR. Based
on our previously published results [34], we performed
RT-PCR on the six subunits most likely to be found in
fibroblasts. We found that nhpESC 4706 expressed all
six nAChR subunits (α1, α5, α7, β1, β2, and γ/ε) as well
as β-actin (Figure 1). After differentiation into fibro-
blasts, nhpESC continue to express nicotinic receptors
in the presence or absence of 100 nM nicotine (Figure 1).
As control, we examined the expression of nAChR sub-
units in the rhesus brain, muscle, and primary cultures
of rhesus lung fibroblasts in the presence or absence of
100 nM nicotine added to the culture medium. We
found that the appropriate subunits were expressed
(Figure 1) as previously described in human tissues [34].
Expression of stem cell markers after in vitro
differentiation
We found that in vitro differentiated fibroblasts had sig-
nificantly decreased mRNA expression of the pluripo-
tency markers Lin28, Sox2, and OCT4 as compared to
undifferentiated controls (Figure 2), while the expression
of the fibroblast differentiation marker vimentin in-
creased significantly (Figure 2). We next confirmed these
results using immunocytochemistry, and found OCT4
expression in undifferentiated nhpESC (Figure 3B), con-
sistent with results by Navara et al. [12]. In addition,
Figure 1 nhpESC express nAChR. We analyzed nAChR receptor subunit expression by RT-PCR. Brain and muscle serve as positive controls.
Bands were sequenced and demonstrated that the correct gene was amplified. B-actin was used as a control for RNA quality, and water-only
reaction was the negative control.
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Figure 2 Differentiated nhpESC expression profile is similar to primary lung fibroblasts. After directed differentiation, gene expression
patterns in NHP-ESC-D match the expression pattern of primate lung fibroblasts and are significantly different from pluripotent NHP-ESC, as deter-
mined by gene array analysis. We compared undifferentiated nhpESC, differentiated nhpESC, and primary NHP fibroblasts for expression of the
pluripotency genes Lin28, Sox2, and OCT4, as well as the fibroblast gene vimentin. In all assays, gene expression of the differentiated nhpESC was
similar to the primary NHP fibroblasts and not the pluripotent parental nhpESC line. Statistical tests used were ANOVA followed by Bonferroni’s
post-test. Differences between NHP-ESC and NHP-ESC-D or adult NHP are significant (p < 0.01). NHP-ESC-D and adult NHP cells were not signifi-
cantly different from one another for the expression of any genes.
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the fibroblast marker smooth muscle actin (SMA)
(Figure 4B). In contrast, after directed differentiation of
the nhpESC into fibroblasts, cells were negative for
OCT4 (Figure 3C) and positive for SMA (Figure 4C),
similar to our control adult rhesus lung fibroblast cul-
tures, which were negative for OCT4 (Figure 3A) and
positive for SMA (Figure 4A).
Differentiated fibroblasts do not form teratomas
Although the parental undifferentiated nhpESC were able
to form teratomas ([12]; personal communication), theFigure 3 Differentiated nhpESC do not express OCT4. Cells were staine
primary lung fibroblasts served as negative controls for OCT4; B: undifferen
4706 differentiated into fibroblasts were negative for OCT4, similar to panehallmark of pluripotent cells, we confirmed that in vitro dif-
ferentiated fibroblasts cannot form teratomas, using the
same Core facility and methods. Cells were injected into
SCID mice in 6 separate injections for a 0% success rate,
comparing with an historical success rate of 92% for tera-
toma formation after injection of pluripotent stem cells in
the Core facility [35]. Histological analysis of the injected
testes four or more months after injection showed an ap-
parent injection site with some inflammation, but no evi-
dence of tumor formation (Additional file 1: Figure S1).
Therefore, we conclude that these cells are differentiated
and do not retain the ability to form teratomas.d by immunofluorescence for the pluripotency marker OCT4. A: NHP
tiated nhpESC 4706 served as positive controls for OCT4; C: nhpESC
l A primary lung fibroblasts.
Figure 4 Differentiated nhpESC express SMA. Cells were stained by immunofluorescence for the fibroblast maker SMA. A: nhp primary lung
fibroblasts served as positive controls for SMA; B: undifferentiated nhpESC 4706 served as negative controls for SMA; C: nhpESC 4706
differentiated into fibroblasts were positive for SMA, similar to panel A primary lung fibroblasts.
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We next compared global gene expression patterns using
an Affymetrix non-human primate gene expression array.
We compared primary NHP lung fibroblast cells with
nhpESC before and after directed differentiation. We deter-
mined that the gene expression profiles of in vitro differen-
tiated fibroblasts are very similar to cultured primary lung
fibroblasts. In fact, we found that differentiated nhpESC
have a global expression pattern that is closer to that of un-
related cultured lung fibroblasts than to the parental undif-
ferentiated nhpESC (Figure 5).
Nicotine-exposed differentiated samples did not cluster
separately from unexposed differentiated samples suggestingFigure 5 Differentiated nhpESC are more similar to primary NHP fibro
expression analysis. Affymetrix gene array analysis was done to assay glo
to similarities in gene expression using cluster analysis. This shows that in v
similar to primary adult lung fibroblasts (222) than with the parental cells frthat the overall the gene expression profiles were similar.
However, there were some significant differences in gene ex-
pression between these two groups. There is a finite group
of less than 100 genes and gene loci that are different
between nicotine exposed and unexposed cultures,
P < 0.001. Using Ingenuity analysis, we found that the genes
that are changed are not representative of all pathways, as
would be expected by chance, and cell cycle-related genes
are over-represented in the cohort. We found that expres-
sion of genes in cell cycle signaling pathways are generally
decreased by nicotine exposure during differentiation, with
the exception of SMAD, which showed increased in expres-
sion (Figure 6). These same genes are increased in adultblasts than their parental cells with respect to global gene
bal gene expression patterns. The lines were then grouped according
itro differentiated fibroblast-like cells (4706D, 3106D, 2706D) are more
om which they were derived (4706UN, 2706UN, 3106UN).
Figure 6 Network profiling shows a central role for N-myc. Using Ingenuity Analysis to compare the expression profiles of fibroblasts
differentiated in the presence of nicotine versus controls, we find that the cell cycle signaling profile has a large number of genes which are
altered (indicated by colored shading) as a result of nicotine exposure during differentiation.
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passages; thus, the decrease in cell cycle signaling pathway is
specific to nicotine exposure during differentiation and is
not a general effect of nicotine on cultured fibroblasts.
We confirmed the expression pattern of N-myc. The
qPCR data demonstrate a significant decrease in N-myc in
nhpESC differentiated cells in the presence of nicotine com-
pared to unexposed differentiated nhpESC in this compari-
son (Figure 7A). Due to the important role of N-myc in
lung development and our interest in this gene, we also con-
firmed that N-myc protein levels were decreased in differen-
tiated fibroblasts that were exposed to nicotine, as
compared to untreated differentiated fibroblasts (Figure 7B).
Nicotine increases doubling time of differentiated nhpESC
N-myc is known to promote proliferation through several
mechanisms, including stimulating ribosome biogenesis
and by inhibiting the cell cycle repressor p15Ink4b(reviewed by [41]. Since Ink4b is a negative regulator of the
cell cycle, expression of N-myc allows cells to cycle more
rapidly [42,43]. In addition to its effects on proliferation, N-
myc has been demonstrated to have a role in the regulation
of cell death, with overexpression of N-myc leading to an in-
crease apoptosis (reviewed by [41]). In order to determine
the downstream effect of decreased N-myc expression
caused by nicotine during differentiation, we performed cell
counts at each passage after differentiation through passage
5 and used regression analysis to analyze the counts. Using
this data, we determined the doubling time of nhpESC after
differentiation into fibroblasts in the presence or absence of
nicotine starting at passage 1 after differentiation. We found
that as nhpESC differentiated into fibroblasts in the pres-
ence of nicotine, the doubling time increased as compared
to control cultures differentiated in the absence of nicotine.
This difference developed over time as cells were passaged,
and was significant at passage 5 (Figure 8).
Figure 7 N-myc is decreased after differentiation in the presence of nicotine. A. The decrease in N-myc expression caused by nicotine
exposure during differentiation was detected by array and confirmed here by real-time PCR. In addition, this demonstrates that fibroblasts
exposed to nicotine after differentiation have the opposite response. B. N-myc protein expression was quantified by immunoblotting at passages
8, 9, and 13. The top panel shows decreased N-myc protein after nicotine treatment as determined by LiCor imaging analysis, with fluorescence
intensity for each sample normalized to β-actin. The bottom panel is a representative blot, showing protein expression at passage 8. Changes
between untreated and nicotine treated cells are significant, P < 0.05 for both qPCR and immunoblotting analyses.
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The acetylcholine signaling pathway has been established
as functional in mouse ESC (mESC), and publications
have demonstrated that mESC express choline acetyl-
transferase and secrete acetylcholine into the culture
medium [44-46]. There are currently a few studies that
examine the effect of nicotine on ESC culture and differ-
entiation; however, they have conflicting results. Nico-
tine increases the expression of OCT4 and Rex1 in
undifferentiated mESC [47]. However, in a separate
study, nicotine inhibited attachment of undifferentiated
hESC to matrigel and led to a corresponding decrease in
OCT4 staining, although the cells remained pluripotent
[48]. Thus, the effect of nicotine on the expression of
pluripotency markers in undifferentiated cells is unclear.
Related studies have examined induced pluripotent stem
cells (iPSC) from mice, and these studies found that
nicotine increased undifferentiated stem cell prolifera-
tion [49,50].
In this study, we document for the first time the pres-
ence of nAChR on primate pluripotent stem cells. Since
ESC differentiation can serve as a model for develop-
ment, these results are a critical discovery, because they
imply that with the presence of these receptors it is pos-
sible for maternal nicotine to affect the earliest stages ofembryonic development, including the ability to differ-
entiate into all the cell types in the body.
During active smoking, smokers have been shown to
obtain a nicotine concentration of 100 nM in the serum
[51]. In addition, smokers have a minimum serum-
nicotine concentration that they maintain throughout
the day, which has been shown to average 100 nM but
ranges between 10 nM and 200 nM for light and heavy
smokers, respectively [52]. Furthermore, since nicotine is
known to cross the placenta, this dose may also be rele-
vant to fetal exposure [1]. Our data show that nAChR
are expressed on nhpESC, therefore, we tested the ability
of a physiologically-relevent dose of nicotine, 100 nM, to
affect differentiation. Using an in vitro differentiation
method, we found that nhpESCs differentiated into fi-
broblasts in the presence of nicotine do not have any ob-
vious differences in cell appearance (Figures 3 and 4);
however, they show significant differences in gene ex-
pression patterns especially with respect to cell cycle-
related genes, most notably N-myc. N-myc is decreased
in expression in the differentiated fibroblasts. This effect
is most dramatic in the early passages after differenti-
ation (passages 1–4); and in some experiments remained
significantly decreased through the final passage exam-
ined, passage 10. The decreased expression of N-myc is
Figure 8 Nicotine exposure during differentiation decreases cell counts and increases doubling time. nhpESC were differentiated in the
presence or absence of 100 nM nicotine. Doubling time was measured by cell counts through passage 5 after differentiation. Data is expressed as
cell counts at passage five, with error bars demonstrating standard deviation, p < 0.001 (upper panel), and this data was converted into doubling
time, show in hours (lower panel). Cells differentiated in the presence of nicotine had a higher doubling time, which was significantly slower than
control starting at passage 5.
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blasts to nicotine (Figure 7). These expression differ-
ences are unique to nhpESCs differentiated in the
presence of nicotine, and are not changed in adult NHP
fibroblasts passaged in nicotine for an equivalent period
of time. This implies that they are disregulated during
differentiation, and this disregulation is maintained mul-
tiple passages after differentiation.
The effects of nicotine exposure on adult fibroblasts
has been studied previously [34,53] and many others
have examined the effect of nicotine on bronchial epi-
thelial cells and lung cancer cells [54-62]. In the lung,
normal fibroblasts and epithelium express functional
nAChR and these receptors are overexpressed in lung
cancer [34,54]. Signaling through these receptors in the
lung leads to activation of signaling pathways consistent
with lung cancer, including the MAPKs and AKT
[34,63]. In addition, short term experiments, including
those up to 48 hours, indicated that bronchial epithelialcells increased expression of nAChR and have increased
nicotinic signaling after exposure [56] and fibroblasts in-
crease fibronectin and nAChR expression [53]. Thus,
both in vivo and in vitro studies show that nAChR have
an endogenous function in the lung, and that exposure
to nicotine alters characteristics of the lung epithelium
and the supporting fibroblasts. A murine lung explant
model has also been used to examine nicotine toxicity,
whereby embryonic lungs were isolated from normal
mice halfway through gestation and then exposed to
nicotine in culture [40]. However, the published data,
whereby lung explants, which are composed of already
differentiated (although immature) cells, are exposed to
nicotine after they are placed in culture, are not likely to
reflect the effects of nicotine on the differentiation
process. Thus, none of these in vivo or in vitro studies
can model the effect of nicotine on the differentiation
process itself, since these cells are already differentiated
at the time that they are exposed.
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tween nicotine exposed and unexposed groups in this
study. The determination that N-myc was decreased in
expression was particularly interesting due to its role in
lung organogenesis. N-myc has been established as an
essential regulator of lung organogenesis using murine
developmental models [64-68]. Our data suggest that
nicotine downregulates N-myc through intracellular sig-
naling initiated by the binding of nicotine to the muscle-
type and/or α7 neuronal nAchR. Our data also show that
nhpESC cultures differentiated into fibroblasts in the
presence of nicotine have a slower doubling time, indica-
tive of either a slower proliferation rate or an increased
cell death rate in the culture. This data, together with
publications that have shown that N-myc is a mediator
of both cell proliferation and cell death, suggest that as a
result of nicotine inhibition of N-myc expression, fibro-
blasts proceed through the cell cycle at a significantly
slower pace than do fibroblasts that are not exposed to
nicotine during differentiation.
Conclusions
In the lung, prenatal cigarette smoke exposure causes
decreased lung function at birth and into childhood
[69-74] as well as increased incidence of asthma and al-
lergies [74]. The mechanisms by which cigarette smoke
has these effects are not known; however, it is modeled
in non-human primates exposed during pregnancy to
nicotine. Studies find that although there are thousands
of chemicals in cigarette smoke, NHP infants subjected
to nicotine alone via a maternal exposure during devel-
opment have increased thickness of the inner airway wall
and altered complexity of branching, decreased respira-
tory volumes, and altered response to airway challenges
[4,5,40,75]. The ability of nicotine to alter N-myc signal-
ing in nhpESC may be one mechanism by which mater-
nal cigarette smoking adversely affects embryonic lung
development, leading to disease later in life.
Additional file
Additional file 1: Differentiated nhpESC do not form Teratomas.
Left Panel: Histology of testes from nude mice 6 months after injection
with approximately 5x105 nhpESC. Histology is the same as Right Panel:
negative control, wherein testes were injected with adult primary NHP
fibroblasts. Table of genes significantly changed after analysis of
GeneChip Rhesus Macaqua Genome Array from Affymetrix. The table lists
genes and genetic loci that were changed as a result of 100 nM nicotine
treatment during differentiation of nhpESC from pluripotency to
fibroblast-like cells, p<0.001.
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